The article discusses the strategic use of race as a genetic category to obtain patent protection and drug approval. Such use of race to obtain extended patent protection for biotechnological inventions indicate a serious distortion of this relationship as commercial imperatives drive simplistic and scientifically weak conceptions of the complex relationship between social categories of race and genetics.